More NewsRead More
Trevena Announces Early Completion of Enrollment of Phase 2a/b Study of TRV130 in Postoperative Pain
October 08, 2014
Trevena Enters into $35 Million Tranched Term Loan Credit Facility
September 22, 2014
Trevena Appoints Adam M. Koppel to the Board of Directors
September 18, 2014
Trevena Granted Key U.S. Composition of Matter Patent for TRV130
September 16, 2014
Trevena Reports Second Quarter 2014 Financial Results
August 12, 2014
Needham & Company Reiterates Bullish Stance on Trevena (TRVN) Amid Positive TRV130 Phase 2b Bunionectomy Results
November 18, 2014
Trevena Announces Positive Top-Line Results From Phase 2a/b Study Of TRV130 In Acute Postoperative Pain
November 17, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here